drugset / Trial / NCT01404429

Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis

NCT01404429

RandomizedParallel-groupSingle-blindTreatment

Summary

To use different starting doses of methotrexate (7.5 mg per week) versus 15 mg per week in patients with rheumatoid arthritis, followed by similar hiking up of dose (2.5 mg per 2 weeks, till max of 25 mg per week). To look at the effect on efficacy ( or speed of efficacy) versus the adverse effects. Hypothesis: There will be no difference in the adverse effects, but better and faster control of disease when starting with a higher methotrexate dose

Timeline

Start
2011-05
Primary completion
2012-06
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 7.5 mg
Subject Methotrexate Small molecule 15 mg

Indications